From Wikipedia, the free encyclopedia

Similar documents
9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

Appendix 3: Taking controlled and prescription drugs to other countries

1. Carrying Personal Medications into Thailand A. Medications containing narcotic drugs of category 2

PRESCRIPTION DRUG MONITORING PROGRAM

Fundamentals of Pharmacology for Veterinary Technicians Chapter 1

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018

See Important Reminder at the end of this policy for important regulatory and legal information.

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients

See Important Reminder at the end of this policy for important regulatory and legal information.

I am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the

Opioid Pain Medications Frequently Asked Questions

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

Mark W. Caverly, Chief Liaison and Policy Section

Review of Controlled Drugs and Substances Act

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

High Risk Medicines Prescribing Policy. July 2017

International Drug Control Conventions. Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol

H 8313 S T A T E O F R H O D E I S L A N D

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

Re: Non-prescription availability of low-dose codeine products

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Curbing Prescription Drug Abuse in Medicaid

Clinical Policy: Opioid Analgesics Reference Number: OH.PHAR.PPA.13 Effective Date: 10/2017 Last Review Date: 6/2018 Line of Business: Medicaid

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Michael M. Miller, MD, FASAM, FAPA

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017

Patient Group Directions Policy

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

See Important Reminder at the end of this policy for important regulatory and legal information.

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

Discuss the recent spread of opioid misuse. Discuss the rise of the current opioid crisis, a national addiction/overdose problem

Prescription Drugs MODULE 5 ALLIED TRADES ASSISTANCE PROGRAM. Preventative Education: Substance Use Disorder

DAWN. In 2009, nearly 4.6 million emergency

In 2009, nearly 4.6 million emergency

UNODC/HONLAF/26/CRP.1

Use of Controlled Substances in Research.

RADARS System International Pre-Symposium 11 May Global Insights in Prescription Drug Misuse

Safe Prescribing and Dispensing of Controlled Drugs. Joint Guidance Medical Council and Pharmaceutical Society of Ireland

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Regulations for the prescribing of Schedule 8 medicines in WA

How to change the legal classification of a medicine in New Zealand

Overview Consumer Health Products Law and Compliance Issues

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof

Opioid Pain Contracts: A Resident Driven Quality Improvement Project

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

9/13/2017 DEA WHO WE ARE: Prescription Drug Abuse. American Association of Service Coordinators September 24-27, 2017 Disney s Coronado Springs Resort

A National Perspective on the Abuse and Diversion of Prescription Drugs

PRESCRIBING GUIDELINES

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

End the Epidemic. Miami-Dade County COMPREHENSIVE COMMUNITY PREVENTION ACTION PLAN

COPYRIGHTED MATERIAL. Introduction

Do not open the test booklet prior to being told to do so.

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

ANNUAL REPORT

2004-L SEPTEMBER

Access to pain therapy in the UN resolutions: worldwide perspective

CLINICAL POLICY DEPARTMENT: Medical

Appearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Coast Community College District BOARD POLICY Chapter 3 General Institution DRUG FREE ENVIRONMENT AND DRUG AND ALCOHOL ABUSE PREVENTION PROGRAM

The Population is Abusing Drugs, but are Drugs Abusing Insurance?

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

POISONS SCHEDULING. Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health

Minister of Social Affairs. Passed No. 73 RTL 2005, 57, 807 Entry into force

White Paper on. Prescription Drug Abuse

Have approved and decreed: Chapter 1 Definitions

Opioid Use and Other Trends

New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drugs and harmful use of alcohol 3.3 Ending the AIDS epidemic and

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER

Substance Use and Misuse in the Military

DEA: Combating the Supply

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES

Interstate dispensing : A case for uniform, intuitive legislation

Recent Developments in FRA s Post-Accident Toxicological Testing Program

France: Millions of medicines seized in largest INTERPOL operation against illicit online pharmacies

A Bill Regular Session, 2015 SENATE BILL 717

Expert Peer Review for Carfentanil

Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?

Federal Trafficking Penalties (As of January 1, 1996)

NBPDP Drug Utilization Review Process Update

Response to Scottish Government A Consultation on Electronic Cigarettes and Strengthening Tobacco Control in Scotland December 2014

Drug Related Deaths in Highland

Systematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E.

quality and safety of pharmacy preparations in Europe

UNIVERSITY STATEMENT FOR STUDENTS ON SUBSTANCE USE/MISUSE

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Prescription Opioid Dependence and Addiction: Experience in the United States

Challenges in Access to controlled medicines

Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

PROGRAM FOR THE USE OF CONTROLLED SUBSTANCES OR PRECURSOR/LIST CHEMICALS IN RESEARCH

Transcription:

1 of 6 11/24/2010 11:43 PM From Wikipedia, the free encyclopedia The regulation of therapeutic goods, that is drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level, or at both state and national levels by various bodies, as is the case in Australia. The role of therapeutic goods regulation is designed mainly to protect the health and safety of the population. Regulation is aimed at ensuring the safety, quality, and efficacy of the therapeutic goods which are covered under the scope of the regulation. In most jurisdictions, therapeutic goods must be registered before they are allowed to be marketed. There is usually some degree of restriction of the availability of certain therapeutic goods depending on their risk to consumers. 1 Regulation by country 1.1 Australia 1.2 Brazil 1.3 Canada 1.4 China 1.5 Europe 1.5.1 United Kingdom 1.5.2 Norway 1.5.3 Iceland 1.5.4 Switzerland 1.6 India 1.7 United States 2 See also 3 References 4 External links Australia

2 of 6 11/24/2010 11:43 PM Therapeutic goods in Australia are regulated by the Therapeutic Goods Administration (TGA). [1] The availability of drugs and poisons is regulated by scheduling under individual state legislation, but is generally under the guidance of the national Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP). Under the SUSDP, medicinal agents generally belong to one of five categories: Brazil Unscheduled/exempt Schedule 2 (S2) - Pharmacy Medicines Schedule 3 (S3) - Pharmacist Only Medicines Schedule 4 (S4) - Prescription Only Medicines Schedule 8 (S8) - Controlled Drugs See also: Illicit drug use in Australia Therapeutic goods in Brazil are regulated by the Brazilian Health Ministry, through its Sanitary Surveillance Agency (equivalent to USA's FDA). There are 5 main categories: Canada Normal Medicines - Cough, cold and fever medicines, antiseptics, vitamins and others. Sold freely in pharmacies and some large supermarkets. Red Stripe Medicines - These medicines are sold only with medical prescription. Antibiotics, Anti allergenics, Anti inflammatories, and other medicines. In Brazil, governmental control is loose on this type; it is not uncommon to buy this type of prescription medicine over the counter without a prescription. Red Stripe Psychoactive Medicines - These medicines are sold only with a "Special Control" white medical prescription with carbon copy, which is valid for 30 days. The original must be retained by the pharmacist after the sale and the patient keeps the carbon copy. Drugs include anti-depressants, anti-convulsants, some sleep aids, anti-psychotics and other non-habit-inducing controlled medicines. Though some consider them habit inducing, anabolic steroids are also regulated under this category. Black Stripe Medicines - These medicines are sold only with the "Blue B Form" medical prescription, which is valid for 30 days and must be retained by the pharmacist after the sale. Includes sedatives (benzodiazepines), some anorexic inducers and other habit-inducing controlled medicines. "Yellow A Form" prescription medicines - These medicines are sold only with the "Yellow A Form" medical prescription - the most tightly controlled, which is valid for 30 days and must be retained by the pharmacist after the sale. Includes amphetamines and other stimulants (such as methylphenidate), opioids (such as morphine and oxycodone) and other strong habit-forming controlled medicines. [2] In Canada, regulation of therapeutic goods are governed by the Food and Drug Act and associated regulations. In addition, thecontrolled Drugs and Substances Act requires additional regulatory requirements for controlled drugs and drug precursors. [3]

3 of 6 11/24/2010 11:43 PM China The regulation of drugs in China is governed by the State Food and Drug Administration. Europe United Kingdom Medicines in the United Kingdom are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). The availability of drugs is regulated by classification by the MHRA as part of marketing authorisation of a product. The United Kingdom has a three-tiered classification system: General Sale List (GSL) Pharmacy medicines (P) Prescription Only Medicines (POM) Within POM, certain agents with a high abuse/addiction liability are separately scheduled under the Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations 2001; and are commonly known as Controlled Drugs (CD). Norway Medicines in Norway are divided into five groups: Class A Narcotics, sedative-hypnotics, and amphetamines in this class require a special prescription form: morphine and its immediate family, heroin, desomorphine, nicomorphine; codeine and its immediate family, dihydrocodeine, ethylmorphine, nicocodeine; morphine relatives: hydromorphone and oxymorphone; codeine relatives: hydrocodone and oxycodone; synthetic opioids: pethidine, methadone, fentanyl, and levorphanol; various sedative-hypnotics: temazepam, methaqualone, pentobarbital, and secobarbital; various stimulants: amphetamines and methylphenidate; flunitrazepam (moved from class B) Class B Restricted substances which easily lead to addiction like: co-codamol, diazepam, nitrazepam, and all other benzodiazepines (with the exception of temazepam and flunitrazepam), phentermine;

4 of 6 11/24/2010 11:43 PM Iceland Class C - All prescription-only substances Class F - Substances and package-sizes not requiring a prescription Unclassifieds - Brands and packages not actively marketed in Norway Medicines in Iceland are regulated by the Icelandic Medicines Control Agency [1] (http://www.imca.is/). Switzerland Medicines in Switzerland are regulated by SwissMedic. [4] The country is not part of the European Union, and is regarded by many as one of the easiest places to conduct clinical trials on new drug compounds. There are 5 categories from A to E to cover different types of Delivery category: A: Single delivery on medical prescription B: Repeated delivery on medical prescription C: Prescription free delivery after consultation of a specialist, restricted to pharmacy/chemist D: Prescription free delivery after consultation of a specialist, restricted to pharmacy, chemist and drugstore E: Prescription free delivery without consultation in all shops/stores India Medicines in India are regulated by CDSCO - Central Drugs Standard Control Organization Under Ministry of Health and Family Welfare. Headed by Directorate General of Health Services CDSCO regulates the Pharmaceutical Products through DCGI - Drugs Controller General of India at Chair. Under Retail and Distribution:- Drugs classified under 5 heads 1. Schedule X drugs Narcotics 2. Schedule H and L Injectables, Antibiotics, Antibacterials 3. Schedule C and C1- Biological Products-example Serums and Vaccines

5 of 6 11/24/2010 11:43 PM Under Manufacturing Practice 1. Schedule N List of the equipment for the efficient running of manufacturing wing, Qualified personnel 2. Schedule M United States Main article: Regulation of therapeutic goods in the United States Therapeutic goods in the United States are regulated by the U.S. Food and Drug Administration (FDA), which makes some drugs available over the counter at retail outlets and others by prescription only. The possession of some substances is prohibited by scheduling under the Controlled Substances Act, under the joint jurisdiction of the FDA and the Drug Enforcement Administration (DEA). Council for International Organizations of Medical Sciences (CIOMS, WHO) Counterfeit drug Drug Efficacy Study Implementation (DESI) Drug prohibition law International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Over-the-counter drug Prescription drug Uppsala Monitoring Centre (WHO) Validation (drug manufacture) World Health Organization European Union EudraLex European Medicines Agency Directive 65/65/EEC1.

6 of 6 11/24/2010 11:43 PM 1. 2. 3. ^ TGA - Therapeutic Goods Administration (http://www.tga.gov.au) ^ Anvisa - The History Of Health Surveillance In Brazil (http://www.anvisa.gov.br/eng/institution/history.htm) ^ "Health Canada: Drugs and Health Products" (http://www.hc-sc.gc.ca 4. /dhp-mps/index-eng.php). Ottawa, Ontario: Health Canada. 2000. http://www.hc-sc.gc.ca/dhp-mps/index-eng.php. Retrieved 02 July 2010. ^ Swissmedic (http://www.swissmedic.ch/?lang=2&lang_old=2) Central Drugs Standard Control Organisation(India) (http://cdsco.nic.in/) Presentation on Drug License Audit Process in India (http://www.ubio.in/diagnostics/drug-license-audit-in-india-things-to-remember/) Retrieved from "" Categories: Pharmaceuticals policy Pharmacy Drug control law Drug safety This page was last modified on 8 November 2010 at 19:38. Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. See Terms of Use for details. Wikipedia is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.